Physiological Response to Salbutamol and Exercise

University of Copenhagen logo

University of Copenhagen

Status

Unknown

Conditions

Healthy

Treatments

Drug: salbutamol
Other: exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT03902106
SALB

Details and patient eligibility

About

The scope of the study is to investigate the physiological response to salbutamol and exercise. A particular focus is on the metabolic response and amine metabolism.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy
  • VO2max of >55 ml/min/kg for men and >50 ml/min/kg for women
  • Body mass index (BMI) < 26

Exclusion criteria

  • Chronic use of beta2-agonist or allergy towards beta2-agonist
  • Serious adverse effects to beta2-agonist
  • Chronic disease deemed by the study responsible medical doctor to interfere with any part of the study
  • Smoking
  • Chronic use of prescription medicine deemed by the study responsible medical doctor to interfere with any part of the study
  • Pregnancy (for women)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups

beta2-agonist and exercise
Active Comparator group
Description:
Subjects undergo exercise training with administration of salbutamol (800 microgram in 12 hours x 2)
Treatment:
Other: exercise
Drug: salbutamol
placebo and exercise
Sham Comparator group
Description:
Subjects undergo exercise training with administration of sham placebo
Treatment:
Other: exercise

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems